M. Klein

发表

Unexpected toxicity following use of gemcitabine as a radiosensitizer in head and neck carcinomas: a veterinary radiation therapy oncology group pilot study.

A. LeBlanc, T. Ladue, J. Turrel, 2004, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

Multimodality therapy for head and neck cancer.

M. Klein, 2003, The Veterinary clinics of North America. Small animal practice.

Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: seven cases (1987-1989).

M. Klein, C. Hutson, C. Willauer, 1992, Journal of the American Veterinary Medical Association.

Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma

D. Thamm, C. London, D. Vail, 2015, BMC Veterinary Research.

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

C. London, P. Bergman, J. Boucher, 2009, Clinical Cancer Research.

Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma

C. London, D. Vail, H. Gardner, 2018, BMC Veterinary Research.

Toxicity criteria of the veterinary radiation therapy oncology group.

T. Ladue, M. Klein, 2001, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

Robert S. Benjamin, Ravi Murthy, Bert Vogelstein, 2014, Science Translational Medicine.

Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study.

G. Ogilvie, B. Powers, B. Kitchell, 2007, Journal of veterinary internal medicine.

Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989).

G. Ogilvie, B. Powers, S. Withrow, 1995, Journal of the American Veterinary Medical Association.

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

D. Thamm, T. Fan, D. Vail, 2017, Journal of veterinary internal medicine.

Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993).

D. Knapp, A. Norris, S. Withrow, 1996, Journal of veterinary internal medicine.

Canine primary renal neoplasms: a retrospective review of 54 cases

G. Ogilvie, A. Norris, S. Withrow, 1988 .

Response of canine mast cell tumors to treatment with oral prednisone.

F. W. Bell, M. Miller, G. Ogilvie, 1994, Journal of veterinary internal medicine.

Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors.

G. Ogilvie, D. Vail, R. Elmslie, 1993, Journal of the American Veterinary Medical Association.

Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-aluminum sulfonated phthalocyanine.

M K Klein, M W Berns, M. Berns, 1991, Journal of the National Cancer Institute.

Survival analysis of 97 cats with nasal lymphoma: a multi-institutional retrospective study (1986-2006).

C. Azuma, J. Poulson, S. Crawford, 2009, Journal of veterinary internal medicine.

Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.

J. Wolchok, P. Bergman, I. Kurzman, 2011, American journal of veterinary research.

Chapter 25 – Tumors of the Female Reproductive System

M. Klein, 2007 .

Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006-2008).

Lynda M Beaver, Gabriele Strottner, Mary K Klein, 2010, Journal of the American Veterinary Medical Association.

Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.

D. Thamm, C. London, D. Vail, 2012, Veterinary and comparative oncology.

Biological activity of toceranib (Palladia) in canine anal gland anal SAC adenocarcinoma (AGASACA)

R. M. Gamblin, D. Thamm, C. London, 2011 .

Evaluation of a novel immunomodulator composed of human chorionic gonadotropin and bacillus Calmette-Guerin for treatment of canine mast cell tumors in clinically affected dogs.

D. McCaw, J. McMichael, R. Rosenthal, 2007, American journal of veterinary research.

Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study

M. Pennell, D. Thamm, C. London, 2015, PloS one.

Amputation and cisplatin for treatment of canine osteosarcoma.

G. Ogilvie, B. Powers, S. Withrow, 1991, Journal of veterinary internal medicine.

A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs.

D. Thamm, M. Martano, J. Hirschberger, 2012, Journal of veterinary internal medicine.

Whole body hyperthermia and heat-sensitizing drugs: a pilot study in canine lymphoproliferative disease.

M. Dewhirst, M. Klein, D. J. Fuller, 1987, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Preclinical pharmacokinetics and antitumor activity of imexon

E. Hersh, R. Dorr, J. Liddil, 2004, Investigational New Drugs.

Vulvovaginectomy and perineal urethrostomy for neoplasms of the vulva and vagina.

A. Norris, S. Withrow, R. Bennett, 1990, Veterinary surgery : VS.

Evaluation of a head-repositioner and Z-plate system for improved accuracy of dose delivery.

W. Lutz, S. Charney, M. Klein, 2009, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

Weekly administration of low-dose doxorubicin for treatment of malignant lymphoma in dogs.

G. Ogilvie, B. Powers, D. Vail, 1991, Journal of the American Veterinary Medical Association.